Cognitive-behavioural therapy has no effect on disease activity but improves quality of life in subgroups of patients with inflammatory bowel disease: a pilot randomised controlled trial

BMC Gastroenterology

Research Article

David Hetzel¹  Patrick Hughes²  Peter Bampton³  Jane M Andrews⁴  Adrian Esterman⁵  Antonina Mikocka-Walus⁶ 

[1] Department of Gastroenterology and Hepatology, Royal Adelaide Hospital, Adelaide, Australia;Nerve-Gut Research Laboratory, Discipline of Medicine, University of Adelaide, Adelaide, Australia;School of Medicine, Flinders University, Adelaide, Australia;Department of Gastroenterology and Hepatology, Flinders Medical Centre, Bedford Park, Australia;School of Medicine, Flinders University, Adelaide, Australia;Department of Gastroenterology and Hepatology, Royal Adelaide Hospital, Adelaide, Australia;School of Medicine, University of Adelaide, Adelaide, Australia;School of Nursing and Midwifery and Sansom Institute for Health Research, University of South Australia, Adelaide, Australia;School of Nursing and Midwifery and Sansom Institute for Health Research, University of South Australia, Adelaide, Australia;Department of Health Sciences, University of York, Area 4, ARRC Building, YO10 5DD, Heslington, UK;School of Psychology, University of Adelaide, Adelaide, Australia;

关键词: Cognitive-behavioural therapy;    Flare;    Mental health;    Psychological;    Quality of life;    Remission;   

DOI  :  10.1186/s12876-015-0278-2

 received in 2014-12-15, accepted in 2015-04-13,  发布年份 2015

来源: Springer

【 摘 要 】

BackgroundStudies have demonstrated usefulness of cognitive-behavioural therapy (CBT) in managing distress in inflammatory bowel disease (IBD); however, few have focused on IBD course. The present trial aimed to investigate whether adding CBT to standard treatment prolongs remission in IBD in comparison to standard therapy alone.MethodsA 2-arm parallel pragmatic randomised controlled trial (+CBT – standard care plus either face-to-face (F2F) or online CBT over 10 weeks versus standard care alone (SC)) was conducted with adult patients in remission. IBD remission at 12 months since baseline was the primary outcome measure while the secondary outcome measures were mental health status and quality of life (QoL). Linear mixed-effect models were used to compare groups on outcome variables while controlling for baseline.ResultsParticipants were 174 patients with IBD (90 +CBT, 84 SC). There was no difference in remission rates between groups, with similar numbers flaring at 12 months. Groups did not differ in anxiety, depression or coping at 6 or 12 months (p >0.05). When only participants classified as ‘in need’ (young, high baseline IBD activity, recently diagnosed; poor mental health) were examined in the post-hoc analysis (n = 74, 34 CBT and 40 controls), CBT significantly improved mental QoL (p = .034, d = .56) at 6 months. Online CBT group had a higher score on Precontemplation than the F2F group, which is consistent with less developed coping with IBD in the cCBT group (p = .045).ConclusionsFuture studies should direct psychological interventions to patients ‘in need’ and attempt to recruit larger samples to compensate for significant attrition when using online CBT.Trial registrationThe protocol was registered on 21/10/2009 with the Australian New Zealand Clinical Trials Registry (ID: ACTRN12609000913279).

【 授权许可】

CC BY   
© Mikocka-Walus et al.; licensee BioMed Central. 2015